Equities

Safeguard Scientifics Inc

SFES:QXR

Safeguard Scientifics Inc

Actions
  • Price (USD)0.975
  • Today's Change-0.025 / -2.50%
  • Shares traded837.00
  • 1 Year change-0.63%
  • Beta0.9870
Data delayed at least 15 minutes, as of Nov 22 2024 16:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Safeguard Scientifics, Inc. is a provider of capital and relevant expertise to technology-driven businesses. The Company offers strategic, operational and management support to certain of its ownership interests, which include defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals; identifying and implementing the business measurements that the Company and others are apply to measure a company’s success; and identifying sources of and providing capital to drive growth. It also continues to hold relatively small equity interests in other enterprises where it does not exert significant influence and do not participate in management activities. The Company's subsidiaries include Bonfield VII, Ltd., Safeguard Delaware, Inc., SFE Properties, Inc., and others.

  • Revenue in USD (TTM)0.00
  • Net income in USD-9.83m
  • Incorporated1953
  • Employees33.00
  • Location
    Safeguard Scientifics Inc150 North Radnor-Chester RoadSuite F-200RADNOR 19087United StatesUSA
  • Phone+1 (610) 293-0600
  • Fax+1 (610) 293-0601
  • Websitehttps://www.safeguard.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alternative Investment Corp0.00-367.26k14.02m3.00---------0.8501-0.85010.00-2.800.00-------5,013.79-147.00---------------6.48--------17.07------
Xsovt Brands Inc-230.00-2.27m15.13m0.00---------0.1416-0.1416-0.00002-0.0753-0.0013-------1,249.08--------100.00---37,918.24---10.04-----66.13---1.90------
CSLM Acquisition Corp0.00494.78k15.58m3.00245.789.6335.60--0.04620.04620.001.180.00------1.47--2.02--------------0.296------124.90------
9F Inc - ADR40.81m1.10m15.66m276.0014.180.0319--0.38370.09380.09383.4641.690.0711--3.39147,857.90-0.4754-17.48-0.5511-20.9657.9973.54-6.69-71.30----0.00---26.53-40.5576.43---34.75--
EQUUS Total Return Inc1.14m-7.06m16.03m0.00--0.3992--14.10-0.5197-0.51970.08372.960.0141--8.04---8.771.44-8.811.4687.6992.37-621.28467.32---1.020.5779-----12.301,247.96202.64----
Renn Fund Inc309.88k1.10m16.63m0.0015.121.06--53.660.15680.15680.04422.240.02--12.97--7.101.927.211.9374.8550.50354.89173.97----0.00--27.9235.0379.10------
Safeguard Scientifics Inc0.00-9.83m16.72m33.00--0.8321-----0.6063-0.60630.001.200.00-------32.475.63-34.696.10-----------0.91930.00------31.09------
IGS Capital Group Ltd100.67k-162.35k17.20m7.00--0.4914--170.88-0.1104-0.11040.05170.13840.2319----14,381.43-37.40-105.97-82.46--16.22---161.27-467.542.14--0.00-------92.34------
IMD Companies Inc439.50k-330.55k17.22m3.00------39.19-0.0053-0.00530.0049-0.00210.430331.325.58146,500.00-32.36-41.61-43.47-58.1633.5249.68-75.21-89.491.05--1.48--26.65---47.11------
BlackRock Virginia Municipal Bond Trust1.42m690.48k17.68m--25.600.892--12.490.43470.43470.891112.480.0428------2.09-0.68302.13-0.689442.0653.8348.79-18.64----0.3688--1.21-3.43185.07-20.13---9.46
Bebuzee Inc0.00-51.91k17.79m4.00---------0.0022-0.00220.00-0.0324---------------------------------100.00--92.80------
Arvana Inc25.05k-549.17k19.41m0.00------774.89-0.0051-0.00510.0002-0.01050.121-------265.27-5,329.73-----84.83---2,192.30-57,453.75---7.8710.06-------769.60------
Data as of Nov 22 2024. Currency figures normalised to Safeguard Scientifics Inc's reporting currency: US Dollar USD

Institutional shareholders

19.43%Per cent of shares held by top holders
HolderShares% Held
Exploration Capital LLCas of 19 Dec 2023852.46k5.10%
Yakira Capital Management, Inc.as of 31 Dec 2023764.39k4.57%
First Manhattan Co LLCas of 31 Dec 2023652.70k3.90%
Maplewood Advisors IM LLCas of 30 Jan 2024494.62k2.96%
Kenneth Rainin Foundationas of 30 Jan 2024301.72k1.80%
Horton Capital Management LLCas of 21 Mar 2024177.39k1.06%
Tralucent Asset Management, Inc.as of 30 Jun 20246.51k0.04%
Huntington National Bank (Investment Management)as of 30 Sep 20241.000.00%
FSA Wealth Management LLCas of 30 Sep 20240.000.00%
More ▼
Data from 30 Jan 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.